Thrombangiitis obliterans (Buerger syndrome);Thrombangiitis obliterans (Buerger-Syndrom)

Deutsche Medizinische Wochenschrift

Volumn 121, Issue 49, 1996, Pages 1543-1548

  Diehm, C ^a   Stammler, F ^a  

^a Klinikum Karlsbad Langensteinbach   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BENCYCLANE; BUFLOMEDIL; CYCLOPHOSPHAMIDE; HEPARIN; ILOPROST; METHOTREXATE; NAFTIDROFURYL; NIFEDIPINE; PENTOXIFYLLINE; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

BUERGER DISEASE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; PROGNOSIS; REVIEW; RISK FACTOR; SMOKING; ADULT; FEMALE; MALE; MIDDLE AGED; MULTICENTER STUDY; SYMPATHECTOMY;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; ASPIRIN; CALCIUM CHANNEL BLOCKERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; ILOPROST; MALE; MIDDLE AGED; MULTICENTER STUDIES; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; RISK FACTORS; SMOKING; SYMPATHECTOMY; THROMBOANGIITIS OBLITERANS;

EID: 0030572913     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043180     Document Type: Review

References (21)

1. Adar, R., M. Z. Papa, Z. Halpern: Cellular sensitivity to collagen in thrombangiitis obliterans. New Engl. J. Med. 308 (1983), 1113-1116.
2. Bollinger, A., B. Hollmann, E. Schneider, A. Fontana: Thrombangiitis obliterans. Diagnose im Licht neuer immunologischer Befunde. Schweiz. med. Wschr. 109 (1979), 537-543.
3. Buerger, L.: Thrombangiitis obliterans. A study of vascular lesions leading to presenile spontaneous gangrene. Amer. J. med. Sci. 136 (1908), 567-580.
4. Diehm, C., K. Amendt: Das Buerger-Syndrom (Thrombangiitis obliterans). Epidemiologie, Klinik, Diagnostik und Therapie. Dtsch. Ärztebl. 90 (1993), C 1875-1881.
5. Fiessinger, J. N., M. Schäfer: Trial of iloprost versus aspirin treatment for critical limb ischemia of thrombangiitis obliterans. Lancet 335 (1990), 555-557.
6. Heidrich, H., F. Hollatz, R. Potthoff: Thrombangiitis obliterans und psychodynamische Befunde. In Heidrich, H. (Hrsg.): Thrombangiitis obliterans, Morbus von Winiwarter-Buerger (Thieme: Stuttgart 1988), 59-62.
7. Hofer-Mayer, T., R. H. Adler, C. Minder, F. Mahler, A. Radvila: Clinical speculation. Is specificity back? This time thrombangiitis obliterans. Psychosom. Med. 57 (1995), 195-201.
8. Leu, H. J.: Thrombangiitis obliterans Buerger. Pathologisch-anatomische Analyse von 53 Fällen. Schweiz. med. Wschr. 115 (1985), 1080-1086.
9. Leu, H. J., B. F. Odenmatt: Immunistochemische Differenzierung proliferierender Intima- und Thrombuszellen in Arterien und Venen bei der Thrombangiitis obliterans. In Breddin, H. K., C. M. Kirchmaier, P., C. Maurer (Hrsg.): Symposium der Deutschen Gesellschaft für Angiologie. Angio Archiv 18 (1989), 49.
10. Lie, J. T.: Thrombangiitis obliterans (Buerger's disease) and smokeless tobacco. Arthr. and Rheum. 31 (1988), 812-813.
11. Matsushita, M., S. Shionoya, T. Matsumoto: Urinary cotinine measurements in patients with Buerger's disease. Effects of active and passive smoking on the disease progress. J. vasc. Surg. 14 (1992), 53-58.
12. Nishikimi, N., T. Saturai, S. Shionoya, M. Ohima: Microcirculatory characteristics in patients with Buerger's disease. Angiology 43 (1992), 312-319.
13. Mills, J. L., J. M. Porter: Buerger's disease (thrombangiitis obliterans). Ann. vasc. Surg. 5 (1991), 570-572.
14. Mills, J. L., J. M. Porter: Thrombangiitis obliterans (Buerger's disease). In Churg, A., J. Churg (Ed.): Systemic vasculitides (Igaku-Shoin: New York 1991), 229-239.
15. Mills, J. L: Buerger's disease. Current status. Vasc. med. Rev. 5 (1994), 139-150.
16. Papa, M. Z., T. Adar: A critical look at thrombangiitis obliterans (Buerger's disease). Perspect. vasc. Surg. 5 (1992), 1-21.
17. Ranft, J., H. Heidrich, C. Meuche: Vitalkapillarmikroskopische Verlaufsbeobachtung der Thrombangiitis obliterans. VASA 23, Suppl. (1988), 62-64.
18. Schmitt, J., C. Schmidt, C. Alan, C. Haller, P. Perrier: Population genetics, immunologic evaluation and Buerger's disease. Projection through a personal study comprising 127 cases of juvenile arteriopathy. Bull. Acad. nat. Med. 177 (1993), 1153-1162.
19. Smolen, J. S., U. Youngchaiyud, P. Weidinger: Autoimmunological aspects of thrombangiitis obliterans (Buerger's disease). Clin. Immunol. Immunopathol. 11 (1978), 168-177.
20. Stammler, F., C. Diehm, E. Hsu, K. Stockinger, K. Amendt: Prävalenz der Hyperhomocysteinämie bei der Thrombangiitis obliterans (Buerger-Syndrom). Spielt Homocystein pathogenetisch eine Rolle? Dusch. med. Wschr. 121 (1996), 1417-1423.
21. Szendro, G., L. Golcman, N. Cristal: Study of the factors affecting blood viscosity in patients with thrombangiitis obliterans. J. vasc. Surg. 7 (1988), 759-762.